The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake

Journal of Psychiatric Research

Volumn 56, Issue 1, 2014, Pages 1-9

  Godar, Sean C ^a,b   Bortolato, Marco ^a   Castelli, M Paola ^c   Casti, Alberto ^c   Casu, Angelo ^c   Chen, Kevin ^a   Ennas, M Grazia ^c   Tambaro, Simone ^b   Shih, Jean C ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Animal models; Monoamine oxidase; Serotonin; Serotonin transporter

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; FLUOXETINE; OXIDOREDUCTASE; AMINE OXIDASE (FLAVIN CONTAINING); SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A DEFICIENCY; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR DISORDER; CORPUS STRIATUM; DOWN REGULATION; ENZYME DEFICIENCY; GENOTYPE; GROOMING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; NULL ALLELE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN REUPTAKE; SEROTONIN UPTAKE; SEROTONINERGIC TRANSMISSION; SOCIAL INTERACTION; 129 MOUSE; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SOCIAL BEHAVIOR; STEREOTYPY; TRANSGENIC MOUSE;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; FLUOXETINE; GROOMING; MALE; MICE, 129 STRAIN; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOAMINE OXIDASE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR; STEREOTYPED BEHAVIOR;

EID: 84903794046     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.04.014     Document Type: Article

References (66)

1. Abudy A., Juven-Wetzler A., Zohar J. Pharmacological management of treatment-resistant obsessive-compulsive disorder. CNS Drugs 2011, 25:585-596.
2. Aghajanian G.K., Graham A.W., Sheard M.H. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors. Science 1970, 169:1100-1102.
3. Alia-Klein N., Goldstein R.Z., Kriplani A., Logan J., Tomasi D., Williams B., et al. Brain monoamine oxidase A activity predicts trait aggression. JNeurosci 2008, 28:5099-5104.
4. Alzghoul L., Bortolato M., Delis F., Thanos P.K., Darling R.D., Godar S.C., et al. Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice. Neuropharmacology 2012, 63:1208-1217.
5. Berman M.E., McCloskey M.S., Fanning J.R., Schumacher J.A., Coccaro E.F. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 2009, 20:714-720.
6. Blier P., de Montigny C. Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 1985, 16:949-955.
7. Bloch M.H., Landeros-Weisenberger A., Sen S., Dombrowski P., Kelmendi B., Coric V., et al. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systemic review. Am J Med Genet Part B Neuropsychiatric Genet 2008, 147B:850-858.
8. Bortolato M., Chen K., Shih J.C. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 2008, 60:1527-1533.
9. Bortolato M., Chen K., Godar S.C., Chen G., Wu W., Rebrin I., et al. Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology 2011, 36:2674-2688.
10. Bortolato M., Frau R., Piras A.P., Luesu W., Bini V., Diaz G., et al. Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotonergic toxicity. Neurotoxicol Res 2009, 15:232-245.
11. Bortolato M., Godar S.C., Davarian S., Chen K., Shih J.C. Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 2009, 34:2746-2757.
12. Bortolato M., Shih J.C. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol 2011, 100:13-42.
13. Bortolato M., Godar S.C., Alzghoul L., Zhang J., Darling R.D., Simpson K.L., et al. Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol 2013, 16:869-888.
14. Bortolato M., Godar S.C., Tambaro S., Li F.G., Devoto P., Coba M.P., et al. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression in MAO-A-deficient mice. Neuropharmacology 2013, 75:223-232.
15. Boulougouris V., Chamberlain S.R., Robbins T.W. Cross-species models of OCD spectrum disorders. Psychiatry Res 2009, 170:15-21.
16. Brigman J.L., Mathur P., Harvey-White J., Izquierdo A., Saksida L.M., Bussey T.J., et al. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex 2010, 20:1955-1963.
17. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
18. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., et al. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
19. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995, 268:1763-1766.
20. Chadman K.K. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 2011, 97:586-594.
21. Coccaro E.F., Kavoussi R.J. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997, 54:1081-1088.
22. Coccaro E.F., Lee R., McCloskey M. Norepinephrine function in personality disorder: plasma free MHPG correlates inversely with life history of aggression. CNS Spectrums 2003, 8:731-736.
23. Coccaro E.F., Lee R.J., Kavoussi R.J. Adouble-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. JClin Psychiatry 2009, 70:653-662.
24. Coccaro E.F., Noblett K.L., McCloskey M.S. Attributional and emotional responses to socially ambiguous cues: validation of a new assessment of social/emotional information processing in healthy adults and impulsive aggressive patients. JPsychiatric Res 2009, 43:915-925.
25. Coccaro E.F., Sripada C.S., Yanowitch R.N., Phan K.L. Corticolimbic function in impulsive aggressive behavior. Biol Psychiatry 2011, 69:1153-1159.
26. Coccaro E.F. What is the nature of serotonergic abnormalities in human aggression?. Biol Psychiatry 2012, 72:980-981.
27. Daw N.D., Kakade S., Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw 2002, 15:603-616.
28. Evrard A., Malagie I., Laporte A.M., Boni C., Hanoun N., Trillat A.C., et al. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur J Neurosci 2002, 15:841-851.
29. Godar S.C., Bortolato M., Frau R., Dousti M., Chen K., Shih J.C. Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int J Neuropsychopharmacol 2011, 14:1195-1207.
30. Gould G.G., Hensler J.G., Burke T.F., Benno R.H., Onaivi E.S., Daws L.C. Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. JNeurochem 2011, 116:291-303.
31. Harmer C.J. Serotonin and emotional processing: does it help explain antidepressant drug action?. Neuropharmacology 2008, 55:1023-1028.
32. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 2006, 30:203-214.
33. Hill R.A., McInnes K.J., Gong E.C., Jones M.E., Simpson E.R., Boon W.C. Estrogen deficient male mice develop compulsive behavior. Biol Psychiatry 2007, 61:359-366.
34. Hollander E., Pallanti S. Current and experimental therapeutics of OCD. Neuropsychopharmacology: the fifth generation of progress 2002, 1648-1665. Lippincott Williams and Wilkins, Philadelphia. K. Davis, D. Charney, J. Coyle, C. Nemeroff (Eds.).
35. Ichimaru Y., Egawa T., Sawa A. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 1995, 68:65-70.
36. Joel D., Ben-Amir E., Doljansky J., Flaisher S. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam. Behav Pharmacol 2004, 15:241-252.
37. Kim-Cohen J., Caspi A., Taylor A., Williams B., Newcombe R., Craig I.W., et al. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 2006, 11:903-913.
38. Kolevzon A., Mathewson K.A., Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. JClin Psychiatry 2006, 67:407-414.
39. Lin P.Y. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:683-689.
40. Li X., Morrow D., Witkin J.M. Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying. Life Sci 2006, 78:1933-1939.
41. Malagie I., Trillat A.C., Jacquot C., Gardier A.M. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an invivo microdialysis study. Eur J Pharmacol 1995, 286:213-217.
42. Matsumoto R., Ichise M., Ito H., Ando T., Takahashi H., Ikoma Y., et al. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. NeuroImage 2010, 49:121-126.
43. McGrath M.J., Campbell K.M., Veldman M.B., Burton F.H. Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior. Behav Pharmacol 1999, 10:435-443.
44. Merens W., Willem Van der Does A.J., Spinhoven P. The effects of serotonin manipulations on emotional information processing and mood. JAffect Disord 2007, 103:43-62.
45. Murray-Close D., Ostrov J.M., Nelson D.A., Crick N.R., Coccaro E.F. Proactive, reactive, and romantic relational aggression in adulthood: measurement, predictive validity, gender differences, and association with intermittent explosive disorder. JPsychiatric Res 2010, 44:393-404.
46. New A.S., Buchsbaum M.S., Hazlett E.A., Goodman M., Koenigsberg H.W., Lo J., et al. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacol Berl 2004, 176:451-458.
47. Paxinos G.F., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
48. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 1992, 50:1683-1690.
49. Phan K.L., Coccaro E.F., Angstadt M., Kreger K.J., Mayberg H.S., Liberzon I., et al. Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry 2013, 73:329-336.
50. Piton A., Poquet H., Redin C., Masurel A., Lauer J., Muller J., et al. 20 ans après: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition. Eur J Hum Genet 2014, 22:776-783.
51. Puglisi-Allegra S., Oliverio A. Naloxone potentiates shock-induced aggressive behavior in mice. Pharmacol Biochem Behav 1981, 15:513-514.
52. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. JNeurosci 2001, 21:305-313.
53. Rebsam A., Seif I., Gaspar P. Dissociating barrel development and lesion-induced plasticity in the mouse somatosensory cortex. JNeurosci 2005, 25:706-710.
54. Reimold M., Smolka M.N., Zimmer A., Batra A., Knobel A., Solbach C., et al. Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study. JNeural Transm 2007, 114:1603-1609.
55. Rosell D.R., Thompson J.L., Slifstein M., Xu X., Frankle W.G., New A.S., et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex physically aggressive personality disordered patients. Biol Psychiatry 2010, 67:1154-1162.
56. Rylands A.J., Hinz R., Jones M., Holmes S.E., Feldmann M., Brown G., et al. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907. Biol Psychiatry 2012, 72:1004-1011.
57. Schilman E.A., Klavir O., Winter C., Sohr R., Joel D. The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system. Neuropsychopharmacology 2010, 35:1026-1039.
58. Scott A.L., Bortolato M., Chen K., Shih J.C. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 2008, 19:739-743.
59. Sharp T., Umbers V., Gartside S.E. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex invivo. Br J Pharmacol 1997, 121:941-946.
60. Siever L.J. Neurobiology of aggression and violence. Am J Psychiatry 2008, 165:429-442.
61. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 1994, 61:59-64.
62. Soliman A., Bagby R.M., Wilson A.A., Miler L., Clark M., Rusjan P., et al. Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits. Psychol Med 2011, 41:1051-1060.
63. Thomas A., Burant A., Bui N., Graham D., Yuva-Paylor L.A., Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology 2009, 204:361-373.
64. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988, 31:959-962.
65. Vitalis T., Cases O., Callebert J., Launay J.M., Price D.J., Seif I., et al. Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. JComp Neurol 1998, 393:169-184.
66. Young S.N., Leyton M. The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacol Biochem Behav 2002, 71:857-865.